| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A blueprint for the worldwide research response to dementia
|
Cataldi, Rodrigo
|
|
|
21 |
8 |
p. 690-691
|
article
|
| 2 |
Andreas Charidimou
|
|
|
|
21 |
8 |
p. 689
|
article
|
| 3 |
Antibiotic neuromuscular junction myasthenic mimetics
|
Uzoigwe, Chika Edward
|
|
|
21 |
8 |
p. 681
|
article
|
| 4 |
Antibiotic neuromuscular junction myasthenic mimetics – Authors' reply
|
Huijbers, Maartje G
|
|
|
21 |
8 |
p. 681
|
article
|
| 5 |
Cerebral amyloid angiopathy criteria: the next generation
|
Graff-Radford, Jonathan
|
|
|
21 |
8 |
p. 674-676
|
article
|
| 6 |
Cognitive-motor dissociation and time to functional recovery in patients with acute brain injury in the USA: a prospective observational cohort study
|
Egbebike, Jennifer
|
|
|
21 |
8 |
p. 704-713
|
article
|
| 7 |
Diagnosis and treatment of orthostatic hypotension
|
Wieling, Wouter
|
|
|
21 |
8 |
p. 735-746
|
article
|
| 8 |
Exercise training and neuroprotection in multiple sclerosis
|
Hvid, Lars G
|
|
|
21 |
8 |
p. 681-682
|
article
|
| 9 |
Further support for rituximab in relapsing multiple sclerosis
|
Naismith, Robert T
|
|
|
21 |
8 |
p. 672-673
|
article
|
| 10 |
Improving prognostication after severe brain injury
|
OBE, Adrian M Owen
|
|
|
21 |
8 |
p. 673-674
|
article
|
| 11 |
Interferon receptor dysfunction in a child with malignant atrophic papulosis and CNS involvement
|
Becker, Lena-Luise
|
|
|
21 |
8 |
p. 682-686
|
article
|
| 12 |
Linda de Vries: intervening early to improve young lives
|
Samarasekera, Udani
|
|
|
21 |
8 |
p. 688
|
article
|
| 13 |
Major advances in sleep neurology: 2002–22
|
Scammell, Thomas E
|
|
|
21 |
8 |
p. 678-680
|
article
|
| 14 |
Moyamoya disease: diagnosis and interventions
|
Ihara, Masafumi
|
|
|
21 |
8 |
p. 747-758
|
article
|
| 15 |
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
|
Svenningsson, Anders
|
|
|
21 |
8 |
p. 693-703
|
article
|
| 16 |
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
|
Ossenkoppele, Rik
|
|
|
21 |
8 |
p. 726-734
|
article
|
| 17 |
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|
Charidimou, Andreas
|
|
|
21 |
8 |
p. 714-725
|
article
|
| 18 |
The drive and determination of John Hughlings Jackson
|
Wijdicks, Eelco
|
|
|
21 |
8 |
p. 692
|
article
|
| 19 |
The importance of genomics in advancing the diagnosis and treatment of dementia
|
Decourt, Boris
|
|
|
21 |
8 |
p. 676-677
|
article
|
| 20 |
Time to revise primary prevention guidelines for stroke and cardiovascular disease
|
Brainin, Michael
|
|
|
21 |
8 |
p. 686-687
|
article
|
| 21 |
West Syndrome and the new classification of epilepsy
|
Knight, Elia M Pestana
|
|
|
21 |
8 |
p. 689
|
article
|
| 22 |
WHO launches its Global Action Plan for brain health
|
The Lancet Neurology,
|
|
|
21 |
8 |
p. 671
|
article
|
Journal description